Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Topic
HOME
·
01177.HK
SBP GROUP (01177.HK): TQ-A3334 20.8% HBsAg clearance at week 48
Tags:
SBP GROUP
01177.HK
Clinical Data
2026-11-09
SBP GROUP (01177.HK): Boehringer deal worth up to US$7bn
Tags:
SBP GROUP
01177.HK
Licensing
2026-11-04
SBP GROUP (01177.HK): Two Hepatitis B Drugs Granted CDE Breakthrough Therapy Status
Tags:
NewTimeSpace
SBP GROUP
01177.HK
2026-10-27
SBP GROUP (01177.HK): TQB2102 Data at ESMO; Phase III Breast Cancer Median PFS 16.4 Months
Tags:
NewTimeSpace
SBP GROUP
01177.HK
2026-10-26
SBP GROUP (01177.HK): TQC2731 Phase III fully enrolled in CRSwNP
Tags:
SBP GROUP
01177.HK
R&D Progress
2026-10-21
SBP GROUP (01177.HK): TQ-A3334, Bepirovirsen Data Picked for AASLD
Tags:
SBP GROUP
01177.HK
R&D Progress
2026-10-14
SBP GROUP (01177.HK): TQC3721 Phase III completes enrolment
Tags:
SBP GROUP
01177.HK
R&D Progress
2026-10-08
SBP GROUP (01177.HK): NDA for TQH2722 "IL-4Rα Antibody" Accepted for Review
Tags:
NewTimeSpace
SBP GROUP
01177.HK
2026-09-16
SBP GROUP (01177.HK): NDA for TQB2102 "HER2 Bispecific ADC" Accepted for Review
Tags:
NewTimeSpace
SBP GROUP
01177.HK
2026-09-16
SBP GROUP (01177.HK): Preclinical Data of Oral STAT6 Degrader TQH5528 Presented at ERS 2026
Tags:
SBP GROUP
01177.HK
R&D Progress
2026-09-08
SBP GROUP (01177.HK): Phase I data of TQC3721 dry powder inhaler (PDE3/4 inhibitor) presented at ERS 2026, showing dose-dependent lung function improvement in COPD
Tags:
SBP GROUP
01177.HK
R&D Progress
2026-09-07
SBP GROUP (01177.HK): FDA Approves IND Application for Self-Developed Class 1 Drug TQB6426 "GPC3 ADC" for Advanced Malignant Tumors
Tags:
SBP GROUP
01177.HK
R&D Progress
2026-09-03
SBP GROUP (01177.HK): Enters Exclusive Licensing Agreement with Cipla for TQB2102, with Deal Value Up to USD 123 Million
Tags:
SBP GROUP
01177.HK
strategic cooperation
2026-08-31
SBP GROUP (01177.HK): Kylo-11 Phase I data published in The Lancet; single dose reduces Lp(a) by up to 97% at week 48
Tags:
SBP GROUP
01177.HK
Clinical Progress
2026-08-31
SBP GROUP (01177.HK): LM-364 "Nectin-4ᵀᴹᴱ ADC" Obtains Clinical Trial Approvals from NMPA and FDA, Accelerating Global Clinical Development
Tags:
SBP GROUP
01177.HK
Clinical Trial
2026-08-28
SBP GROUP (01177.HK): New Indication of Benmelstobart plus Chemotherapy Sequentially with Anlotinib as First-Line Treatment for Squamous NSCLC Approved for Marketing
Tags:
SBP GROUP
01177.HK
R&D Progress
2026-08-07
Sino Biopharmaceutical (01177.HK): Second-Generation Flurbiprofen Patch Approved for Marketing
Tags:
Sino Biopharmaceutical
01177.HK
2026-08-06
SBP GROUP(01177.HK): NDA for BCL‑2 Inhibitor TQB3909 Accepted, for Treatment of CLL/SLL
Tags:
SBP GROUP
01177.HK
New Drug Application
2026-08-04
SBP GROUP(01177.HK): HER2 Bispecific ADC TQB2102 Receives Third CDE Breakthrough Therapy Designation for HER2-Low
Tags:
SBP GROUP
01177.HK
breakthrough drug
2026-08-03
SBP GROUP (01177.HK): Establishes Joint Venture with Indonesia’s Tempo Scan Holding 51% Stake to Expand Innovative Drug Market in Southeast Asia
Tags:
SBP GROUP
01177.HK
joint venture company
2026-07-27
1
2
Next
Research
HK Stock Connect Daily Report: AUX ELECTRIC +13.32% Leads - 20261117
Research
HK AI Concept Stock Daily: BIRENTECH +8.16% on Chips Rally - 20261117
Finance
BAIC MOTOR (01958.HK): 112 battery-swap assets offered at RMB 277.9m
Finance
NewTimeSpace | HK Close: HSI -1.03%, Semis and Paper & Packaging Gain
Finance
FDB HOLDINGS (01826.HK): SFC flags highly concentrated ownership
Research
HK shares ETFs Daily Report: Tracker Fund +1.84%, HK IPO Theme -4.76% — Nov 17, 2026
Finance
SSY GROUP (02005.HK): noradrenaline 1ml:2mg wins NMPA approval
Finance
WISDOM EDU INTL (06068.HK): FY2026 net profit seen at RMB 15.6m
Finance
WEIHAI BANK (09677.HK): RMB 500m 3-year financial bond issued
Research
Hong Kong Recently Listed Stocks Daily Report: AUX ELECTRIC Rises 13.32% to Lead; Consumer and Robotics Sectors Rebound-20261117
Scan QR Code
Download App